The invention provides compounds of Formula I:
1
which may be in the form of pharmaceutical acceptable salts or compositions, are useful in treating diseases or conditions in which &agr;7 nicotinic acetylcholine receptors (nAChRs) are known to be involved.
本发明提供了I式化合物:1,其可以是药物可接受的盐或组合物的形式,用于治疗已知涉及α7
尼古丁乙酰胆碱受体(nAChRs)的疾病或病况。